Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 1 , Pages 23-31 , February 2010

Bone Accretion in Adolescents Using the Combined Estrogen and Progestin Transdermal Contraceptive Method Ortho Evra: A Pilot Study

  • Zeev Harel, MD

      Affiliations

    • Division of Adolescent Medicine, Hasbro Children's Hospital, Providence, Rhode Island, USA
    • Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    • Corresponding Author InformationAddress correspondence to: Zeev Harel, MD, Division of Adolescent Medicine, Hasbro Children's Hospital, 593 Eddy St, Providence, RI 02903
    • ,
  • Suzanne Riggs, MD

      Affiliations

    • Division of Adolescent Medicine, Hasbro Children's Hospital, Providence, Rhode Island, USA
    • Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    • ,
  • Rosalind Vaz, MD

      Affiliations

    • Division of Adolescent Medicine, Hasbro Children's Hospital, Providence, Rhode Island, USA
    • Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    • ,
  • Patricia Flanagan, MD

      Affiliations

    • Division of Adolescent Medicine, Hasbro Children's Hospital, Providence, Rhode Island, USA
    • Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
    • ,
  • Dalia Harel, MSc

      Affiliations

    • Division of Adolescent Medicine, Hasbro Children's Hospital, Providence, Rhode Island, USA
    • ,
  • Jason T. Machan, PhD

      Affiliations

    • Department of Biostatistics, Rhode Island Hospital, Providence, Rhode Island, USA

References 

  1. Abrams LS, Skee D, Natarajan J, et al. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril. 2002;77:S3
  2. Smallwood GH, Meador ML, Lenihan JP, et al. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol. 2001;98:799
  3. Audet MC, Moreau M, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive: A randomized controlled trial. JAMA. 2001;285:2347
  4. Abrams LS, Skee DM, Natarajan J, et al. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise. J Clin Pharmacol. 2001;41:1301
  5. Sibai BM, Odlind V, Meador ML, et al. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril. 2002;77:S19
  6. Archer DF, Bigrigg A, Smallwood GH, et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril. 2002;77:S27
  7. Abrams LS, Skee DM, Natarajan J, et al. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Br J Clin Pharmacol. 2002;53:141
  8. Zacur HA, Hedon B, Mansour D, et al. Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril. 2002;77:S32
  9. Zieman M, Guillebaud J, Weisberg E, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: analysis of pooled data. Fertil Steril. 2002;77:S13
  10. Rubinstein ML, Halpern-Felsher BL, Irwin CE. An evaluation of the use of the transdermal contraceptive patch in adolescents. J Adolesc Health. 2004;34:395
  11. Harel Z, Riggs S, Vaz R, et al. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol. 2005;18:85
  12. Chetkowski RJ, Meldrum DR, Steingold KA, et al. Biologic effects of transdermal estradiol. N Engl J Med. 1986;314:1615
  13. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 1991;72:374
  14. Slowinska-Srzednicka J, Zgliczynski S, Jeske W, et al. Transdermal 17 beta estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor I in postmenopausal women. J Endocrinol Invest. 1992;15:533
  15. Kelly JJ, Rajkovic IA, O'Sullivan AJ, et al. Effects of different oral estrogen formulations on insulin-like growth factor-I growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf). 1993;39:561
  16. Campagnoli C, Biglia N, Altare F, et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol. 1993;7:251
  17. Ljunghall S, Lindh E, Johansson AG. Endocrine interactions of insulin-like growth factor I on bone. Acta Paediatr Suppl. 1994;399:178
  18. Rosen CJ, Donahue LR, Hunter SJ. Insulin-like growth factors and bone: The osteoporosis connection. Proc Soc Exp Biol Med. 1994;206:83
  19. Ho KK, Weissberger AJ. Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res. 1992;7:821
  20. Warren MP, Miller KK, Olson WH, et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and ostopenia: an open-label extension of a double blind, placebo-controlled study. Contraception. 2005;72:206
  21. Holioua L, Anderson JJ. Lifetime calcium intake and physical activity habits: independent and combined effects on the radial bone of healthy premenopausal Caucasian women. Am J Clin Nutr. 1989;49:534
  22. Kasper MJ, Peterson MGE, Allegrante JP, et al. Knowledge, beliefs, and behaviors among college women concerning the prevention of osteoporosis. Arch Fam Med. 1994;3:696
  23. Trends in oral contraceptive development and utilization looking to the future. Contracept Rep. 1997;7:4
  24. Polatti F, Perotti F, Filippa N, et al. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995;51:221
  25. Cromer B, Stager M, Bonny A, et al. Depot Medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health. 2004;35:434
  26. Ortho Evra (norelgestromin/ethinyl estradiol). US Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/drug/infopage/othoevra/default.hum. Accessed November 11, 2008.
  27. Wang Q, Nicholson PHF, Suuriniemi M, et al. Relationship of sex hormones to bone geometric properties and mineral density in early pubertal girls. J Clin Endocrinol Metab. 2004;89:1698
  28. Wang Q, Alén M, Nicholson PHF, et al. Differential effects of sex hormones on peri- and endocortical bone surfaces in pubertal girls. J Clin Endocrinol Metab. 2006;91:277
  29. Fortunati N, Fissore F, Fazzari A, et al. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′ 5′-monophosphate and protein kinase. Endocrinology. 1996;137:686
  30. Garnero P, Sornay-Rendu E, Delmas PD. Decreased bone turnover in oral contraceptive users. Bone. 1995;16:499
  31. Harel Z, Gold M, Cromer B, et al. Bone mineral density in postmenarchal adolescent girls in the United States: Associated biopsychosocial variables and bone turnover markers. J Adolesc Health. 2007;40:44
  32. Friend KE, Hartman ML, Pezzoli SS, et al. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women—a clinical research center study. J Clin Endocrinol Metab. 1996;81:2250
  33. Bellantoni MF, Vittone J, Campfield AT, et al. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab. 1996;81:2848
  34. Leonard MB, Shults J, Wilson BA, et al. Obesity during childhood and adolescence augments bone mass and bone dimensions. Am J Clin Nutr. 2004;80:514
  35. Klein KO, Larmore KA, de Lancey E, et al. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab. 1998;83:3469
  36. Elgan C, Samsioe G, Dykes AK. Influence of smoking and oral contraceptives on bone mineral density and bone remodeling in young women: a 2-year study. Contraception. 2003;67:439
  37. Clark MK, Sowers MF, Dekordi F, et al. Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery. Osteoporos Int. 2003;14:396

PII: S1083-3188(09)00184-3

doi: 10.1016/j.jpag.2009.04.008

Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 1 , Pages 23-31 , February 2010

Article Tools

* Image Usage & Resolution